Dr. Matthew Daniel Roby, DO

Dr. Roby practices at Carilion Roanoke Memorial Hospital in Roanoke, Virginia, part of Carilion Clinic.

Dr. Roby's NPI, 1265708457, was assigned on April 1, 2012. Dr. Roby holds Virginia license 0102205157.

Dr. Roby's primary practice is Carilion Roanoke Memorial Hospital, at 1906 Belleview Avenue, SE, Roanoke, VA 24014 in Roanoke City. The practice phone is (540) 981-7000.

Dr. Roby's primary practice is Carilion Roanoke Memorial Hospital in Roanoke, Virginia, part of Carilion Clinic. Dr. Roby is also affiliated with Carilion New River Valley Medical Center. The medical group on file is Carilion Clinic. Dmand AI also links Dr. Roby to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roby practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Roby's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Roby is licensed in Virginia.

CMS data shows 5,070 Medicare services from Dr. Roby across 27 procedure codes in 2024, for 2,714 Medicare patients. Medicare paid $140,174 for them.

CMS counts 2,714 Medicare patients who saw Dr. Roby in 2024. The largest group is 75 to 84, with 1,085 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roby's median patient age at 73, with 52% women.

In 2024, Dr. Roby wrote 4,928 Medicare Part D claims for 816 patients. 82% of them were for generic drugs. CMS names the drug for 4,698 of them, across 47 drugs with 11 or more claims each, at $987,544 in total drug cost. In 2023, CMS named 3,877 claims across 43 drugs.

Dr. Roby accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Roby, published from 2017 to 2024. Dr. Roby has published most often in Case Rep Med. Dr. Roby's most frequent co-authors are Kelechukwu Uzoma Okoro, MD, Adegbenga A. Bankole, MD and John A. Kern.

CMS Open Payments shows 45 general payments to Dr. Roby from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. Abbott Laboratories paid the most, $2,165.